Genetic Polymorphisms in LDLR, APOB, PCSK9 and Other Lipid Related Genes Associated with Familial Hypercholesterolemia in Malaysia

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lye, Say Hean ^a   Chahil, Jagdish Kaur ^a   Bagali, Pramod ^a   Alex, Livy ^a   Vadivelu, Jamunarani ^b   Ahmad, Wan Azman Wan ^b   Chan, Siew Pheng ^b   Thong, Meow Keong ^b   Zain, Shamsul Mohd ^b   Mohamed, Rosmawati ^b  

^a INFOVALLEY Group of Companies INFOVALLEY Life Sciences Sdn Bhd Mines Waterfront Business Park   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; APOB GENE; ARTICLE; ASIAN; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; LDLR GENE; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MICROARRAY ANALYSIS; PCSK9 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; APOLIPOPROTEINS B; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPID METABOLISM; MALAYSIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPROTEIN CONVERTASES; RECEPTORS, LDL; SERINE ENDOPEPTIDASES;

EID: 84875987106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060729     Document Type: Article

References (46)

1. Rader DJ, Cohen J, Hobbs HH, (2003) Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest 111: 1795-1803.
2. Alonso R, Defesche JC, Tejedor D, Castillo S, Stef M, et al. (2009) Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform. Clin Biochem 42: 899-903.
3. Stamler J, Wentworth D, Neaton JD, (1986) Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256: 2823-2828.
4. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, et al. (1980) Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 46: 649-654.
5. Castelli WP, Anderson K, Wilson PW, Levy D, (1992) Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol 2: 23-28.
6. Steinberg D, Witztum JL, (1990) Lipoproteins and atherogenesis. Current concepts. JAMA 264: 3047-3052.
7. Marais AD, (2004) Familial hypercholesterolaemia. Clin Biochem Rev 25: 49-68.
8. Soutar AK, Naoumova RP, (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4: 214-225.
9. Anderson RG, (2003) Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology. Trends Cell Biol 13: 534-539.
10. Lee JC, Weissglas-Volkov D, Kyttala M, Sinsheimer JS, Jokiaho A, et al. (2007) USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease. Arterioscler Thromb Vasc Biol 27: 2222-2227.
11. de Knijff P, Havekes LM, (1996) Apolipoprotein E as a risk factor for coronary heart disease: a genetic and molecular biology approach. Curr Opin Lipidol 7: 59-63.
12. Alonso-Orgaz S, Moreno L, Macaya C, Rico L, Mateos-Caceres PJ, et al. (2006) Proteomic study of plasma from moderate hypercholesterolemic patients. J Proteome Res 5: 2301-2308.
13. Ando H, Nishimura Y, Nemoto T, Takamura T, Nagai Y, et al. (2001) Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita). Endocr J 48: 113-118.
14. Meng L, Ruixing Y, Yiyang L, Xingjiang L, Kela L, et al. (2010) Association of LIPC -250G>A polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Lipids Health Dis 9: 28.
15. Dinu I, Mahasirimongkol S, Liu Q, Yanai H, Sharaf Eldin N, et al. (2012) SNP-SNP interactions discovered by logic regression explain Crohn's disease genetics. PLoS One 7: e43035.
16. Onay VU, Briollais L, Knight JA, Shi E, Wang Y, et al. (2006) SNP-SNP interactions in breast cancer susceptibility. BMC Cancer 6: 114.
17. Al-Allaf FA, Coutelle C, Waddington SN, David AL, Harbottle R, et al. (2010) LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives. Int Arch Med 3: 36.
18. Dorsch MF, Lawrance RA, Durham NP, Hall AS, (2001) Familial hypercholesterolaemia is underdiagnosed after AMI. BMJ 322: 111.
19. Rees A, (2008) Familial hypercholesterolaemia: underdiagnosed and undertreated. Eur Heart J 29: 2583-2584.
20. Jarvik GP, Brunzell JD, Motulsky AG, (2008) Frequent detection of familial hypercholesterolemia mutations in familial combined hyperlipidemia. J Am Coll Cardiol 52: 1554-1556.
21. Al-Khateeb A, Zahri MK, Mohamed MS, Sasongko TH, Ibrahim S, et al. (2011) Analysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia. BMC Med Genet 12: 40.
22. Khoo KL, Tan H, Liew YM, (2000) Familial hyperlipidaemia in Malaysian children. Med J Malaysia 55: 249-258.
23. Khoo KL, Van Acker P, Tan H, Deslypere JP, (2000) Genetic causes of familial hypercholesterolaemia in a Malaysian population. Med J Malaysia 55: 409-418.
24. Khoo KL, van Acker P, Defesche JC, Tan H, van de Kerkhof L, et al. (2000) Low-density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia. Clin Genet 58: 98-105.
25. Khoo KL, Tan H, Liew YM, Deslypere JP, Janus E, (2003) Lipids and coronary heart disease in Asia. Atherosclerosis 169: 1-10.
26. Azian M, Hapizah MN, Khalid BA, Khalid Y, Rosli A, et al. (2006) Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB). Malays J Pathol 28: 7-15.
27. Fouchier SW, Defesche JC, Umans-Eckenhausen MW, Kastelein JP, (2001) The molecular basis of familial hypercholesterolemia in The Netherlands. Hum Genet 109: 602-615.
28. Betteridge J (2000) Lipids and vascular disease: current issues. London: Martin Dunitz.
29. Leigh SE, Foster AH, Whittall RA, Hubbart CS, Humphries SE, (2008) Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 72: 485-498.
30. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
31. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365-371.
32. Casado M, Vallet VS, Kahn A, Vaulont S, (1999) Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J Biol Chem 274: 2009-2013.
33. Ribeiro A, Pastier D, Kardassis D, Chambaz J, Cardot P, (1999) Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J Biol Chem 274: 1216-1225.
34. Pastier D, Lacorte JM, Chambaz J, Cardot P, Ribeiro A, (2002) Two initiator-like elements are required for the combined activation of the human apolipoprotein C-III promoter by upstream stimulatory factor and hepatic nuclear factor-4. J Biol Chem 277: 15199-15206.
35. van der Vleuten GM, Isaacs A, Hijmans A, van Duijn CM, Stalenhoef AF, et al. (2007) The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia. J Lipid Res 48: 193-200.
36. Yuan G, Wang J, Hegele RA, (2006) Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ 174: 1124-1129.
37. Alex L, Chahil JK, Lye SH, Bagali P, Ler LW, (2012) Differences in allele frequencies of autosomal dominant hypercholesterolemia SNPs in the Malaysian population. J Hum Genet 57: 358-362.
38. Austin MA, Hutter CM, Zimmern RL, Humphries SE, (2004) Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 160: 407-420.
39. Lombardi P, Sijbrands EJ, van de Giessen K, Smelt AH, Kastelein JJ, et al. (1995) Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing. J Lipid Res 36: 860-867.
40. Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, et al. (2005) Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 37: 1243-1246.
41. Salanti G, Amountza G, Ntzani EE, Ioannidis JP, (2005) Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 13: 840-848.
42. Cox DG, Kraft P, (2006) Quantification of the power of Hardy-Weinberg equilibrium testing to detect genotyping error. Hum Hered 61: 10-14.
43. Balding DJ, (2006) A tutorial on statistical methods for population association studies. Nat Rev Genet 7: 781-791.
44. Trapani L, Pallottini V (2010) Age-Related Hypercholesterolemia and HMG-CoA Reductase Dysregulation: Sex Does Matter (A Gender Perspective). Curr Gerontol Geriatr Res: 420139.
45. Matasconi M, Parini P, Angelin B, Rudling M, (2005) Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: effects of hypophysectomy and growth hormone treatment. Biochim Biophys Acta 1736: 221-227.
46. Rudling M, Parini P, Angelin B, (1997) Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. J Clin Invest 99: 2239-2245.